By
Adrianne Appel2025-08-05T16:23:00
The Securities and Exchange Commission (SEC) and Department of Justice (DOJ) have ended a seven-year review of GE HealthCare Technologies’ China unit for possible violations of the Foreign Corrupt Practices Act (FCPA), the company announced.
The SEC wrote a letter to the company on May 16, and the DOJ wrote on May 28, informing GE HealthCare they were closing their investigations and taking no further action, GE HealthCare, a spin-off of the General Electric Company, said.
The agencies began their investigations of the company in 2018 for its activities in certain provinces in China.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-11-26T21:41:00Z By Trevor Treharne
’Tis the season of giving. For multinationals, compliance in gifts and entertainment policies in Asia is not about exporting Western rules, but embedding global standards in a language and culture local teams trust.
2025-11-24T22:23:00Z By Oscar Gonzalez
The dismissal of charges against SolarWinds for alleged cybersecurity lapses related to a 2020 Russian cyberattack in 2020 are the latest in a continuing pattern of leniency for corporations by the Trump administration.
2025-11-24T21:19:00Z By Jaclyn Jaeger
Since the start of the Trump Administration, the Department of Justice has been winding down a number of Foreign Corrupt Practices Act investigations with little public attention. This second article further explores how and why these FCPA matters have been closed.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud